Series B2 · Healthtech
UltraSight raises $24m Series B2 for US expansion
Alive HealthTech Growth Fund led financing to expand cardiac ultrasound workflows in intensive care and circulatory support.
Deep Insight, Star51 Capital, Connecticut Innovations, eHealth Ventures, Mayo Clinic Ventures, NYU and Iron Nation also participated.
The funding will support US commercialization and cardiovascular partnerships. UltraSight’s Echosystem combines clinician training, AI-guided image acquisition and physician-led interpretation to extend access to cardiac ultrasound.
Use of funds
US commercial expansion
Develop intensive care and circulatory support workflows
Expand cardiovascular partnerships
Funding history
Series B2 · This round$24M